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Commensal lactobacilli produce bile salt hydrolase (BSH) enzymes whose role in intestinal 
survival is unclear. Twenty-six strains of Lactobacillus salivarius, from different sources, all 
harboured a bsh1 allele on their respective megaplasmid, related to the plasmid-borne bsh1 gene of 
the probiotic strain UCC118. A second locus (bsh2) was found in the chromosome of two strains 
that had higher bile resistance levels. Four BSH1-encoding allele groups were identified, defined 
by truncation or deletions involving a conserved residue. In vitro analyses showed that this allelic 
variation correlated with widely varying bile-deconjugation phenotypes. Despite very low activity 
of the UCC118 BSH1 enzyme, a mutant lacking this protein had significantly lowered bile 
resistance, both in vitro and during intestinal transit in mice. However, the overall bile-resistance 
phenotype of this and other strains was independent of the bsh1 allele type. Analysis of the L. 
salivarius transcriptome upon exposure to bile and cholate identified a multiplicity of stress 
response proteins and putative efflux proteins that appear to broadly compensate for, or mask, the 
effect of allelic variation of bsh genes. BSH enzymes with different bile degrading kinetics, though 
apparently not the primary determinants of bile resistance in L. salivarius, may have additional 




























Lactobacilli are among the species most commonly used as probiotic agents, due to the wide 
range of consumer benefits associated with their consumption (34). During intestinal transit, the 
host suppresses bacterial survival and persistence by using a variety of mechanisms, including low 
pH, rapid transit time, and production of bile, digestive enzymes and antimicrobial peptides. Bile 
resistance is one of the main criteria used for selecting bacterial strains for probiotic applications 
(50). Bile is a detergent solution of organic and inorganic compounds, which varies in composition 
in different animals (44). The major constituents include bile acids, cholesterol and phospholipids 
(2). Human bile acids are synthesized in the liver and then circulated in the gastrointestinal tract, 
with high concentrations in the duodenum, jejunum and proximal ileum (48). Bile is toxic to 
bacterial cells, causing membrane damage, secondary structure formation in RNA, DNA damage, 
and oxidative and osmotic stresses (2).  
Production of bile salt hydrolase enzymes is a common bile resistance mechanism in bacteria. 
Bile salt hydrolases (BSH), or conjugated bile acid hydrolases (CBAH; EC 3.5.1.24) belong to the 
choloylglycine hydrolase family which form part of the N-terminal nucleophilic (Ntn) hydrolase 
superfamily of enzymes (2). The choloylglycine hydrolase family also includes penicillin V 
amidase (PVA; EC 3.5.1.11), whose evolutionary relationship with BSH has been elucidated for 
the Bifidobacterium longum proteins (30). BSH enzymes act upon a wide range of bile acids 
conjugates and salts including six major human conjugated bile acids (taurocholic acid, TCA; 
taurodeoxycholic acid, TDCA; taurochenodeoxycholic acid, TCDCA; glycocholic acid, GCA; 
glycodeoxycholic acid, GDCA; glycochenodeoxycholic acid, GCDCA). Homologues of the bsh 
gene have been detected in many intestinal bacteria (28). In some pathogens including Listeria 

























required for the persistence of L. monocytogenes in the murine intestine (3) and for the ability of 
Brucella to infect mice (16).  
The presence and genetic organization of bsh genes in lactobacilli is very variable. In addition 
to presence in single copy in some species, multiple copies of bsh were annotated in Lactobacillus 
acidophilus NCFM (bshA and bshB), Lactobacillus johnsonii NCC533 (three genes) and 
Lactobacillus gasseri ATCC33323 (two genes) (32). In some Lactobacillus strains, bsh was part of 
an operon (20). Disruption and deletion of bsh in lactobacilli caused loss of corresponding activity 
against tauro/glyco-conjugated bile acids (CBA) (36, 42). Resistance of bsh mutants of 
Lactobacillus amylovorus and Lactobacillus plantarum to bile acids/salts was reduced compared to 
the respective wild type strains (13, 14, 25). However, no convincing in vivo experiments have so 
far demonstrated that bsh contributes to bile resistance in these or other probiotic bacteria. A triple 
bsh mutant of L. johnsonii NCC533 (i.e. lacking all three BSH proteins) did not exhibit 
significantly reduced murine gut persistence compared to the parental strain (17). The role of bsh 
in intestinal tract survival of probiotic lactobacilli is generally unclear. 
 BSH enzymes from a variety of sources differ in structure, substrate specificity, and optimal 
temperature and pH range for enzyme function (24, 49, 53). BSH subunit sizes range from 28 kDa 
to 56 kDa, and the enzymes are generally more active at an acidic pH range (4-7). The most 
thermostable BSH was detected in Brevibacillus sp whose optimal temperature is 60oC (53). BSH 
enzymes recognize bile acids on both the cholate steroid nucleus and the amino acid moiety. The 
crystal structure of C. perfringens BSH revealed that activity is conferred by a hydrophobic pocket 
that recognizes the cholyl moiety of the substrate (49). The crystal structures and biochemical 


























Within the phylogenetically diverse genus Lactobacillus, BSHs have only been biochemically 
characterized from L. acidophilus PF01 (42, 46) and L. johnsonii 100-100 (20). Inactivation of 
bshB in L. acidophilus NCFM revealed that the strain lost hydrolytic activity for tauro-conjugated 
bile salts (42). Given that lactobacilli are the main contributors to BSH activity in the murine and 
chicken intestinal tracts (27, 57), and could be physiologically important when produced by 
lactobacilli in the human gut, biochemical characterization of the corresponding BSH enzymes is 
desirable. 
The unconjugated bile acids or free bile acids (FBA) generated by BSH enzymes are more 
toxic than the conjugated substrate forms, and they strongly inhibit the growth of intestinal bacteria 
(4). Bacteria that hydrolyze bile must therefore detoxify or remove FBAs, by one of these major 
strategies: precipitation or 7-dehydroxylation and precipitation at moderately acidic pH; 
catabolism by CoA-ligase; transport (efflux) outside the bacterial cell. In Bacteroides fragilis, the 
presence or absence of BSH activity correlates with production of 7-α-hydroxysteroid 
dehydrogenase (54). How BSH-producing Lactobacillus species like L. salivarius, that are 
non-producers of 7-α-hydroxysteroid dehydrogenase, resist FBAs is not clear, and motivated our 
transcriptome analysis of cholate response in this study.  
Bile exposure appears to have driven the dissemination and evolution of bsh genes in the 
human intestinal microbial metagenome (28). However, there is also evidence that the production 
levels and the enzymatic activity of BSH are not directly related to overall bile resistance levels (25, 
43). In addition to bsh, other genes (pva, btlB) and the sigma factor σB were shown to contribute to 
bile resistance in L. monocytogenes EGDe (3). Furthermore, microarray analysis of the 
bile-induced transcriptome identified genes including MDR transporters, chaperone, esterase, and 













Lactobacillus reuteri ATCC55730 (47, 62). Genes involved in DNA repair, oxidative response, 
transcriptional regulation, dGTP hydrolysis, membrane composition, and cell wall synthesis were 
differentially expressed upon exposure of Enterococcus faecalis or L. plantarum WCFS1 cells to 
bile (6, 7).  
L. salivarius UCC118 is a well characterized strain (11) with probiotic properties (18). This 
strain harbours a 242 kb megaplasmid pMP118, that interdigitates with chromosomally-encoded 
functions to confer metabolic flexibility (37, 45). L. salivarius is common in the gastrointestinal 
tract of many animals including humans (1), and chickens (27), but its survival mechanisms in vivo 
are poorly understood. In this study, we therefore examined the contribution of allelic variants of 


























MATERIALS AND METHODS 
Bacterial strains, plasmids and growth conditions. Bacterial strains and plasmids used in 
this study are listed in Table 1. L. salivarius was grown under microaerobic conditions (5% CO2) in 
de Man-Rogosa-Sharpe (MRS) medium (Oxoid Ltd., United Kingdom) at 37oC. E. coli was grown 
in Luria-Bertani (LB) broth (51) with aeration at 37oC. Lactococcus lactis was grown at 30oC in 
M17 broth (Oxoid Ltd., United Kingdom) supplemented with 0.5% (wt/vol) glucose. 
Erythromycin (Em) and chloramphenicol (Cm) were used at 5 μg/ml for L. salivarius and L. lactis. 
Tetracycline (Tet) was added at 5μg/ml for L. salivarius and 10μg/ml for L. lactis. Ampicillin 
(Amp) and chloramphenicol were supplemented at 50 µg/ml and 34 μg/ml for E. coli, respectively. 
DNA manipulation. Primers used for PCR were purchased from MWG Biotech (Ebersberg, 
Germany) and are listed in Table S1 of the Supporting Material. Pwo polymerase (Roche, 
Mannheim, Germany) was used for PCR amplifications. Restriction enzymes, T4 DNA ligase, and 
PCR purification kits were purchased from Roche (Mannheim, Germany) and used according to 
their instructions. For making constructs (pEB118 and pEB1046) for overexpression of bsh1 
(LSL_1801) and 1046bsh1, KOD HiFi polymerase (Novagen, Darmstadt, Germany) and 
In-Fusion™ Dry-Down PCR cloning kit (Clontech, U. S. A.) were used for PCR amplification and 
cloning according to manufacturers’ instructions. Plasmid DNA electrotransformation, L. 
salivarius genomic DNA isolation, pulsed-field gel electrophoresis (PFGE) (plug preparation, S1 
nuclease treatment and electrophoresis) were performed as described previously (21). Southern 
blot analysis followed a standard protocol (51). 
Analysis of bsh expression by qRT-PCR. bsh1 transcription levels in L. salivarius strains 
were determined relative to that of the groEL gene. RNA was isolated from both exponential and 













RNA-easy kit (Ambion, Cambridgeshire, United Kingdom). Random primers were purchased 
from MWG Biotech, Germany. 500 ng of RNA was reverse transcribed using Improm-II reverse 
transcriptase (Promega). PCR amplification was performed according to the manufacturer’s 
instructions. Briefly, a 12.5 μl PCR reaction consisted 6.25 μl 2 ¯ master mix (Biogene, United 
Kingdom), 50 nM of each primer, 1/60,000 SYBR green I (Biogene, United Kingdom) and 1 μl 
cDNA. The qRT-PCR amplifications were performed on an ABI Prism 7000 using SYBR green I.  
Type I microarray procedures. The L. salivarius array contains 1500 Agilent quality control 
spots and 60 nt oligonucleotides corresponding to 2184 genes (including annotated pseudogenes) 
in the genome of L. salivarius UCC118. A maximum of four probes21 replicatesfor each gene 
were designed from each open reading frame (smaller genes have fewer probes) by eArray 
(https://earray.chem.agilent.com/earray/, Agilent Technologies). These probes were spaced 





 oC and 60oC. 
The probes were printed in spots, were randomly distributed across the array, and were printed by 
Agilent Technologies. The array design and microarray data can be found at EMBL-EBI 









Overnight cultures of L. salivarius UCC118, LS201 and LS201Δbsh1 were diluted 50 fold in 
MRS without antibiotics and grown at 37oC to an OD600 of 0.3. The cultures were divided in two 
and were either untreated or treated with 0.1% porcine bile or 1mM cholate (sodium cholate 
hydrate, Sigma C6445). After 15 min incubation, 12 ml samples were harvested by centrifugation 
(13,000 ¯ g for 15 sec) at room temperature. Cell pellets were washed once with RNAprotect 
Bacteria Reagent (Qiagen) and immediately frozen at -80oC. Cells were disrupted by a bead-beater 
homogenizer (three times 1 min treatment with 1 min intervals on ice). Total RNA was isolated 



















treatment. RNA quality was checked by Agilent Bioanalyzer 2100 using the RNA 6000 Nano assay 
kit (Agilent). 4 μg RNA derived from cells treated or untreated was used for complementary DNA 
synthesis and labeled with Cy3/5-dCTP (GE Healthcare Life Sciences) with a SuperScript™ II 
reverse transcriptase kit (Invitrogen) at 42oC for 90 min. Cy3-and Cy5- labeled cDNAs were 
purified using the MinElute PCR purification kit (Qiagen) and quantified using the NanoDrop 
ND-1000 UV-VIS spectrophotometer (NanoDrop Technologies, Rockland, DE). An Agilent Oligo 
aCGH/CHIP-on chip hybridization kit was used for hybridization. Hybridizations were performed 
in an Agilent hybridization oven (G2545A) at 65oC for 24 hrs. Slides were scanned using Agilent 
Microarray Scanner System (G2505B) with Agilent scan control software version 7.0 for the 44k 
microarray at resolution of 5μm and Red and Green PMT at 10. Agilent Feature Extraction 
software verion 9.1 was used for feature extraction. Microarray data outliers were removed with 
the Grubbs test (26). P values were calculated according to the Cyber-T test (38).  
Phylogenetic analysis. BSH sequences were aligned by ClustalW provided by Molecular 
Evolutionary Genetics Analysis (MEGA ) software version 4 (55). The neighbor-joining tree of 
BSH sequences was built by running MEGA4 using the p-distances amino acid model with 500 
bootstrap replications. Penicillin V acylase (PVA) (P12256) from Bacillus sphaericus that belongs 
to the same choloylglycine hydrolase family (CBAH, PF02275 [http://pfam.sanger.ac.uk]) as BSH 








Construction of L. salivarius bsh1 and lacZ mutants. L. salivarius bsh1 and lacZ integrants 
were obtained by plasmid integration as described previously (59). Primer pairs FF025-FF026, 
FF027-FF028 and JP076-JP081 were used to PCR amplify internal fragments of bsh (1046bsh1 
and LSL_1801) and lacZ (LSL_0376), respectively. The corresponding PCR products were 


























LL108 was used as the cloning host for these constructs. The resulting plasmids pLS216 and 
pLS217 were transformed into L. salivarius LS201 for construction of the bsh1 (LSL_1801) 
integrant (LS201Δbsh1) and the lacZ (LSL_0376) integrant (LS201ΔlacZ). pLS218 was 
transformed into L. salivarius JCM1046 to generate the 1046bsh1 integrant JCM1046Δbsh1. 
Integrants of pORI constructs were selected through curing of pVE6007 by growth at elevated 
temperature, as described previously (59). 
BSH plate assay, bile minimum inhibition concentration (MIC) assay and bile challenge 
experiment procedures. L. salivarius strains were tested for hydrolase activity against tauro- or 
glyco-conjugated bile acids (CBA) by using a plate assay method (12). Overnight MRS broth 
cultures were streaked on MRS agar supplemented with 0.5 % (wt/vol) sodium taurodeoxycholate 
hydrate (TDCA, Sigma T0875) or 2 mM sodium glycodeoxycholate (GDCA, Sigma G3258). The 
plate was then incubated anaerobically for 48 hrs at 37oC. BSH activity was detectable when 
deoxycholic acid precipitated in the agar medium below and around a colony. For detecting BSH 
activity of E. coli expressing various constructs, an optimized LB bile acids medium (for 1 l, agar 
15 g, tryptone 10 g, yeast extract 5 g, NaCl 5 g, CaCl2 2H2O 0.35 g, glucose 10 g, IPTG 1 mM, 
pH6.5) containing 5 g/l TDCA or 2mM GDCA (10) was used.  
To measure minimum inhibition concentrations (MIC), overnight cultures of L. salivarius 
strains were inoculated at 1% into MRS medium containing different concentrations of porcine or 
bovine bile (Sigma, B8631 and B8381) or GDCA. Cultures were then incubated at 37oC for 24 hrs 
and 10 μl was spotted on MRS agar plates. Growth on the plate was indicative of resistance to the 
corresponding bile/bile salt concentration of the strain. 
For survival experiments, L. salivarius LS201, JCM1046 and the corresponding bsh1 or lacZ 


























were washed once with MRS broth followed by resuspension in MRS broth containing a sub-lethal 
concentration of porcine bile (0.2% for LS201 and its derivatives, 0.1% for JCM1046 and its 
derivative) and incubated at 37oC (5 % CO2) for 5 hrs. Samples were removed from the culture at 
different time intervals, were diluted, and plated on MRS, MRS Em 5 or MRS Tet 5 plates for 
viable cell counting. 
Expression and purification of BSH. The genes for 118BSH1 (LSL_1801) or its homologs 
from strain JCM1046 were amplified by PCR using primers EBF-EB118R or EBF-EB1046R. 
Purified PCR products were cloned into the linearised T7 promoter-based pOPINE expression 
vector (OPPF) by In-Fusion™ reactions. The resulting plasmids pEB118 and pEB1046 were 
transformed into strain E. coli BL21(DE3)pLysS for overexpressing C-6 ¯ His-tagged bsh. For 
production of BSH, 40 ml of E. coli BL21(DE3)pLysS (pEB118 or pEB1046) overnight culture for 
expression of corresponding bsh was inoculated into a biofermentor (Biolab, B. Braun Biotech Ltd., 
Germany) charged with 2 l of LB medium supplemented with 34 μg/ml Cm and 50 μg/ml Amp. 
The culture was grown at 37oC with oxygen supplementation and agitation of 200 rpm to an OD600 
value of 0.6. The culture was then induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) 
at 37oC for 5 hrs. For expression of 118bsh1, the culture was immediately cooled to 20oC followed 
by induction with 0.1mM IPTG for 20 hrs. The cells were harvested by centrifugation and the cell 
pellet was resuspended in 80 ml 50 mM Tris-HCl pH7.5, 500 mM NaCl, 20 mM imidazole. Cells 
were disrupted by sonication. Cell debris was removed by centrifugation at 45,000 ¯g for 30 min 
at 4oC. BSH was purified by immobilized metal ion affinity chromatography (IMAC) and gel 
filtration with the ÄKTAprime™ plus FPLC (GE Healthcare Life Sciences). BSH was eluted with 
buffer (50 mM Tris-HCl pH7.5, 500 mM NaCl, 500 mM imidazole) from a HisTrap HP 1ml 


























concentrator and then applied to a Superdex 200 gel filtration column. BSH was eluted with a 
buffer containing 20 mM Tris-HCl pH 7.5, 200 mM NaCl, 10 mM DTT. Fractions containing BSH 
were pooled and concentrated.  
L. salivarius BSH protein and activity assay. BSH specific activity was determined by 
measuring amino acid release from conjugated bile salts (30, 56). The reaction was set up in PCR 
strip tubes. In a 20 μl reaction, a mixture of 0.1 M sodium phosphate buffer pH 5.5, 10 mM DTT, 
10 mM T/G-CBA and BSH (100 nM 1046BSH1 or 400 nM 118BSH1) was incubated at 37ºC (30 
min for 1046BSH1 or 3 hrs for 118BSH1). Immediately, the reaction was stopped by adding 20 μl 
15% (wt/vol) trichloroacetic acid. The samples were then centrifuged at 10,000 ¯ g for 1 min. 5 μl 
of the supernatants or their appropriate dilutions was mixed with 95μl ninhydrin reagent (19 ml 
ninhydrin solution contains 5 ml 1% ninhydrin in 0.5 M citrate buffer pH 5.5, 12 ml glycerol, 2 ml 
0.5 M citrate buffer, pH 5.5) and incubated at 100oC for 15 min. Reactions were cooled and 
transferred to a 96-well plate and absorbance at 570 nm read. The absorbance at 570 nm was 
converted into the amount of amino acid, by reference to a glycine standard curve. One unit of 
BSH activity was defined as the amount of enzyme that released one μmol of taurine/glycine from 
substrate per min. The same reaction conditions were used to determine the Vmax and Km for the 
1046BSH1 enzyme with the enzyme concentration fixed at 140 nM the substrate concentration 
varied from 0.5 mM to 8 mM. To determine the optimum pH for BSH activity, 10 mM GDCA was 
used for 118BSH1, 10 mM TDCA was used for 1046BSH1, as these were shown to be good 
substrates for the respective enzymes. The following buffering systems were used in this study: 0.1 
M citrate phosphate buffer (for pH 3 to pH 5); 0.1 M sodium phosphate buffer (for pH 5.5 to pH 8).  
Protein concentration was determined by the Bradford method (5) using Bio-Rad Protein 



















Murine intestinal tract survival. Spontaneous rifampicin-resistant (rifR) mutant of L. 
salivarius strain LS201Δbsh1 and streptomycin-resistant (strepR) mutant of strain LS201ΔlacZ 
were isolated as follows. A 20 ml of overnight cultures of respective LS201 derivatives was 
centrifuged. Cell pellets were resuspended in 200 μl of PBS, and plated onto MRS/Tet5 
supplemented with 50 μg/ml rifampicin or 1 mg/ml streptomycin. Murine inoculation experiments 
were approved by the institutional ethics committee and complied with all relevant legislation. For 
each group, five 9-week old Balb/C male mice were orally administered with either 100 μl PBS 
(control group), or a mixture of L. salivarius LS201Δbsh1 and LS201ΔlacZ cells at a dose of 109 
CFU each strain, in 100 μl (competitive experiment group) by oral gavage. Mice were given access 
to water and food after administering Lactobacillus strains or PBS. Faeces was collected 
individually at different time intervals and resuspended in 1 ml PBS by votexing to homogenize. 
The faeces suspensions were centrifuged at 100 ¯ g for 2 min. Supernatants were taken for 
dilution and viable cell counting on Tet-Rif or Tet-Strep for LS201Δbsh1 and LS201ΔlacZ, 
respectively. The study was powered to determine differences between groups at a significant level. 
Data pertaining to the comparative survival of strains over time was analyzed by two-way analysis 





























Distribution of bsh alleles in L. salivarius strains. The genome of L. salivarius UCC118 
contains two genes that were originally annotated as choloylglycine hydrolases: the 
chromosomally located LSL_0518, and the megaplasmid located LSL_1801 (11). The amino acid 
sequence of the LSL_0518 gene product shows slightly higher identity (31%) to characterized 
penicillin V acylases from Bacilllus subtilis (accession CAJ77223) and L. plantarum WCFS1 
(CAD65471) (31) than that (29%) to the conjugated bile acid hydrolase (2RF8_A) from 
Clostridium perfringens. The sequence of the LSL_1801 product is 53% identical to functionally 
characterized conjugated bile acid hydrolase (CAD00145) from L. monocytogenes EGDe (3), 
while it shows lower residue identity (34%) to penicillin V acylase (ZP_00394048.1) from Bacillus 
anthracis str. A2012.  
LSL_1801 is located on the megaplasmid pMP118 in strain UC118, and megaplasmids with a 
related replication origin were previously detected in all 33 L. salivarius strains examined (37). 
Among 28 L. salivarius strains investigated by Southern hybridization (Fig. 1), a single bsh allele 
located on the circular megaplasmid was detected in all strains, except JCM1230 (not shown). A 
second bsh locus was detected in strain JCM1046 by annotation of a draft genome sequence (Raftis 
and O’Toole, unpublished data). This BSH, which will be the subject of a separate study, is 45 % 
identical to LSL_1801 at protein level, and its chromosomal gene did not hybridize with the 
LSL_1801 probe. A PCR survey failed to amplify this second bsh gene from any other L. salivarius 
strain except LMG14476. For clarity, we refer to LSL_1801 related proteins as BSH1 (preceded 
where appropriate by the strain number), and we designated the additional enzyme present in 
JCM1046 and LMG14476 as BSH2. The apparently universal presence of bsh1 homologues in L. 


























biological significance that we proceeded to investigate. 
 
Allelic variation of bsh1 in L. salivarius. bsh1 (LSL_1801) homologues from 26 L. salivarius 
strains were amplified and sequenced. The predicted BSH1 proteins from these L. salivarius strains 
were greater than 93% identical to each other (Fig. 2). Based on the sequence alignment, the BSH1 
proteins could be divided into 4 major groups (Table 2 and Fig. 3). Group A (UCC118 group) 
BSH1 sequences are identical to each other. Relative to other BSH proteins (Fig. 2), group A 
proteins contain an internal deletion of 8 amino acids (165-171: NPI/VGVLTN) in the middle of 
the sequence. Group B (CCUG47825 group) BSH1 sequences are also identical to each other. The 
sequence has a C-terminal truncation and it has the same internal deletion as in group A. In Group 
C (JCM1046 group) BSH1 sequences are complete, relative to all the other sequences aligned. 
CCUG43299BSH1 is identical to 01M14315BSH1; other group C proteins are 94-99% identical. 
Group D BSH1 proteins (NCIMB8816 and JCM1042) represent a pseudogene group (data not 
shown); these sequences are interrupted by a stop codon at amino acid 74. BSH1 proteins in group 
C contain all reported conserved active site amino acids in BSH enzymes [cysteine 2 (Cys 2), 
arginine 16 (Arg 16), aspartic acid 19 (Asp 19), asparagine 79 and 171 (Asn 79 and 171) and 
arginine 224 (Arg 224)] (48) as indicated in Fig. 2. Group A and B BSH1 molecules lack the 
conserved Asn 171 residue. The sequence of bsh2 from strain LMG14476 is identical to that from 
strain JCM1046. Pair-wise sequence alignment indicates that BSH2 shows highest sequence 
identity to BSH (ZP_03073770) from L. reuteri 100-23 (68.9%), compared to 47.2% identity with 
JCM1046 BSH1. Furthermore, the L. salivarius BSH2 sequence contains all 6 conserved BSH 



























BSH phylogenetic analysis. The phylogeny of BSH1 and BSH2 from L. salivarius strain 
JCM1046 was investigated by tree construction with representative Gram-positive bacterial BSH 
sequences, employing PVA from B. sphaericus as the out-group. BSH sequences from 
Gram-positive bacteria could thus be divided into a clostridial clade and a non-clostridial clade 
(Fig. S1). All lactobacillus BSH sequences were in the non-clostridial clade, and most of them 
were in a large group represented by the L. salivarius BSH1 branch and the L. salivarius BSH2 
branch. A few Lactobacillus BSHs separated into the Bifidobacterium BSH group. Lack of 
complete bsh gene concordance with 16S gene phylogeny supports dissemination of the 
corresponding bsh genes by selection and lateral gene transfer (28). 
 
BSH activity and bile resistance of L. salivarius strains. BSH activity in Lactobacillus cells 
was detected by a plate method (12). BSH activity is indicated by either white colonies with 
surrounding precipitation zones, in the case of high activity, or opaque white colonies without 
precipitation haloes, as shown for representative strains in Fig. 3. L. salivarius strains with group A 
BSH1 enzymes exhibited weak BSH activity against TDCA in this assay (formation of opaque 
white colonies) exemplified in Fig. 3, and summarized in full in Table 2. Strains harbouring the 
group B bsh1 allele failed to demonstrate convincing activity in the plate assay. Apart from strains 
JCM1046 and LMG14476 that have two bsh genes in their genomes, BSH activity in group C 
strains was only detected against sodium taurodeoxycholate hydrate (TDCA). Strains JCM1046 
and LMG14476 showed activity against both TDCA and sodium glycodeoxycholate (GDCA), 
suggesting the latter activity was due to the presence of the additional bsh2 allele. Among the 
group D strains (pseudogene group), white colony formation was recorded for strain NCIMB8816 




















detectable by hybridization or PCR also lacked detectable BSH activity in this assay (not shown). 
L. salivarius strains exhibited widely variant resistance levels to bile and bile components, as 
shown by the minimum inhibition concentration (MIC) values in Table 2. Strains whose genomes 
encoded BSH1 enzymes from the same group did not necessarily have the same MIC for either bile 
or conjugated bile acids (CBA). The non-BSH producing strain JCM1230 had a higher MIC for 
GDCA than some BSH producing strains. All the L. salivarius strains were resistant to the highest 
concentration (100 mM) of TDCA tested (data not shown). The MIC values for GDCA for all L. 
salivarius strains were very similar except for those of strains JCM1046 and LMG14476 which 
could resist much higher concentrations (>15 mM) of GDCA than the other L. salivarius strains 
that have BSH1 only. This strengthens the linkage of the bsh2 allele with GDCA deconjugation. 
 
Comparison of bsh1 transcription levels in L. salivarius strains. The preceding analysis 
identified inconsistencies in bsh1 allele groupings and bile MIC values. Among the potential 
reasons for this was varying bsh1 transcription levels. Nucleotide comparison of amplified 
flanking sequences upstream of bsh1 revealed that the presumptive promoter and ribosome binding 
site of 24 L. salivarius bsh1 genes appeared to be very conserved, and could be described by the 
following consensus sequence: 
ATTATTAG-TTKAWW-N6-8-TTGATAC-TYTWAT-A-GGAAG-N8-ATG. (-35, -10 boxes and 
ribosome binding site were underlined; where K= T or G, W=A or T, Y= C or T, R= A or G, D= A, 
G or T, N= A, T, G or C). The transcription level of bsh1 in three representative L. salivarius strains 
(UCC118, CCUG47825 and JCM1046, allele groups A through C) was analyzed by qRT-PCR at 
two growth phases, using groEL as a reference gene, and relating expression levels to those of bsh1 
































modestly but significantly (p < 0.01) higher than that of strain UCC118. The increase was only 
1.36-fold and 1.31-fold for exponential and stationary phases, respectively. Notwithstanding minor 
sequence differences, the consensus promoter region of bsh1 and the qRT-PCR data collectively 
indicate that bsh1 is transcribed at broadly similar levels in the L. salivarius strains examined. Thus, 
the lack of correlation of L. salivarius bile resistance levels and their BSH1 grouping is probably 
not due to the transcription level of bsh1. 
 
Biological characterization of BSH1 enzymes in L. salivarius. To further characterize the 
function of bsh1, the gene was interrupted in strain LS201, and strain JCM1046, by plasmid 
integration. LS201 is a derivative of UCC118 generated by curing of resident plasmid pSF118-20; 
this strain was used to allow complementation of the mutated bsh1 allele with a copy cloned into a 
low-copy number vector that we derived from pSF118-20 (21). The integration of plasmid pLS216 
into pMP118 in strain LS201Δbsh was confirmed by Southern hybridization (Fig. 5A). A control 
integrant strain of LS201 (LS201ΔlacZ) was constructed by disruption of the lacZ gene with 
plasmid pLS217. JCM1046Δbsh1 was generated by integration of pLS218 into the megaplasmid 
pMP1046. Disruption of bsh1 in strain LS201 led to a significant reduction in resistance to porcine 
bile (Fig. 6A). The relative survival rates of LS201, LS201ΔlacZ and LS201Δbsh were 93%, 29% 
and 0.2% after 2 hrs of bile challenge. The cell numbers of LS201Δbsh were reduced by four logs 
after 5 hrs bile challenge. Expression of bsh1 (LSL_1801) in trans from its native promoter 
(i.e.when cloned in plasmid pLS219) restored the bile resistance of LS201Δbsh to the resistance 
level of the LS201ΔlacZ integrant. Transformation by the empty vector pLS209 had no effect (Fig. 
6A). The JCM1046Δbsh1 mutant also appeared more sensitive to bile than the wild type strain (Fig. 


























LS201. Some 20% of JCM1046Δbsh1 cells survived 2 hrs of bile challenge. BSH plate assay 
showed that the JCM1046Δbsh1 mutant had completely lost deconjugation activity for TDCA (not 
shown) but it still deconjugated GDCA, increasing the likelihood that bsh2 as responsible for 
activity against GDCA. Paradoxically however, the GDCA MIC values for LS201Δbsh and 
JCM1046Δbsh1 were also decreased compared to their parental strains (Table 2), indicating some 
degree of activity of bsh1 against both TDCA and GDCA (see also below).  
Porcine bile was used for the bile challenge experiment, because it is very similar in 
composition to human bile (44). A previous study showed that L. salivarius UCC118 can survive 
transit through the murine GI tract, (18) but the importance of bile resistance for this transit was 
unknown. Spontaneous rifampicin or streptomycin-resistant derivatives of the bsh1 mutant 
(LS201Δbsh) and the control strain (LS201ΔlacZ) were tested for competitive survival in a murine 
GI tract transit model. In the control group of mice inoculated with phosphate-buffered saline 
(PBS), no antibiotic resistant bacteria were detected in faeces at any time points. Both LS201Δbsh 
and LS201ΔlacZ strains were detected 2 hrs after administration (Fig. 6C), but there were 
significantly more cells recovered of LS201ΔlacZ than that of LS201Δbsh at times 2, 4, and 6 
hours after administration. Cells of the LS201Δbsh mutant could not be cultured 24 hours after 
administration, whereas the LS201ΔlacZ strain was still detectable in faeces 3 days after the oral 
administration. Survival of strain LS201Δbsh after transit through the murine GI tract was 
significantly lower than that of strain LS201ΔlacZ (p < 0.01).  
 
Biochemical characterization of recombinant BSH1 proteins. The 118bsh1 and 1046bsh1 
genes, representing BSH1 groups A and C, were amplified and cloned into the E. coli expression 


























assay, only E. coli strains that harboured the construct for expressing 1046BSH1 showed 
deconjugation activity on both TDCA and GDCA (data not shown); E. coli harbouring the 118bsh1 
construct had no detectable BSH activity. 118BSH1 and 1046BSH1 were over-expressed in E. coli 
Rosetta BL21 (DE3) and purified (Fig. 7). The predicted molecular weights of 118BSH and 
1046BSH1 are 35,714 Da and 36,494 Da, respectively. Based on their elution profiles on calibrated 
size exclusion chromatography columns, both 118BSH1 and 1046BSH1 were a mixture of dimer 
and monomer forms (data not shown), although the dimer to monomer ratio for 1046BSH1 (2:1) 
was twice that for 118BSH1 (1:1). Repeated attempts to express and purify the group B protein 
(internal deletion and carboxy-terminal truncation) were unsuccessful, because the protein 
(47825BSH1) was insoluble, and could not be refolded from inclusion bodies. 
A comparison of the specific activities of the two enzymes (118BSH1 and 1046BSH1) on a 
range of tauro- and glyco- CBAs was undertaken (Fig 8A). This indicated that the enzymes had 
different substrate preferences. The 118BSH1 had greater activity against the glyco-CBAs than 
against the tauro-CBAs. The limited activity against tauro-CBAs varied with very low 
(<1μmol/mg) activity against the TCA compared with 8.8 and 9.8 μmol/mg for TDCA and TCDCA 
respectively. Activity against the better substrates, glyco-CBAs, also indicated that the CA 
conjugate was the poorest of the three tested (68, 45, 58 μmol/mg for GDCA, GCA and GCDCA 
respectively), and showed a clear preference for glyco-conjugated bile acids. Of significance was 
the switch in substrate preference for the 1046BSH1 enzyme, with clearly higher catalytic 
capabilities against the tauro-conjugated substrates. The activity of this enzyme against 
glyco-conjugated substrates was higher (ranging from 104-441 μmol/mg) than the 118 enzyme 
activity for all substrates tested. More importantly, there was a very large increase in the activity 


























TCDCA, compared with < 10 μmol/mg for the best tauro-conjugated substrate tested with 
118BSH1. This would suggest that the 8 amino acid deletion in the 118BSH1 enyzyme has a 
dramatic impact on the rate of hydrolysis and substrate selection.  
It is evident from data presented Fig. 8 that both variants of BSH1 have activity over a broad 
range of pH but with a slight shift in pH optima. 1046BSH1 had maximal activity at pH 5.5 and 
118BSH1 an optimum of pH 6.5. The more active 1046BSH1 enzyme was chosen for kinetic 
analysis. Using TCA as a substrate (0.5 – 8 mM), the Km and Vmax were calculated using a standard 
Michaelis-Menten kinetic analysis and were determined to be 1.979 mM and 3.169 nmol sec-1 
respectively (Fig 8B). The turnover number kcat, defined as Vmax/[E], was 22.636 sec-1.  
 
The bile and cholate-induced transcriptomes of L. salivarius. To identify mechanisms for 
resisting bile other than BSH, and ways in which the deconjugation products of BSH might be 
dealt with, the bile and cholate induced transcriptomes of L. salivarius were investigated, and are 
summarized diagrammatically in Fig. 9. The complete datasets are available at ArrayExpress under 
accession no. XXX (Note: for review purposes, please see temporary Supporting Information 
Tables S2 and S3). Responsive genes were located on both the chromosome and the megaplasmid 
pMP118, with some discrete clusters evident. Many more genes were differentially expressed upon 
exposure to cholate than to bile, but each treatment led to differential expression of distinct gene 
clusters. As is evident from Fig. 9, cholate exposure caused differential expression of genes 
uniformly distributed around the chromosome and pMP118. Bile treatment affected expression of 
genes uniformly distributed round pMP118, but preferentially in the “top half” or ori-side of the 
chromosome. This is indicative that genes that are differentially regulated during bile stress also 


























Challenge with 0.1% porcine bile resulted in a total of 123 and 68 genes being differentially 
expressed in LS201 and the LS201 Δbsh1 mutant, respectively, using as cut-off a p value < 0.05 
and a ≥ 2-fold expression change. Inability to produce BSH1 did not result in significantly different 
genes being expressed in response to bile, nor different levels of expression. The bsh1 gene itself 
was not induced by bile exposure. In both the wild-type and bsh1 mutant (Table S2), a conserved 
set of genes was up-regulated, including those involved in carbohydrate transport and metabolism, 
energy production and conversion, cell wall/membrane/envelope biogenesis, amino acid transport 
and metabolism, and inorganic ion transport and metabolism. A mannose specific PTS system 
(LSL_1713-6) was highly induced (8-10 fold) by bile. Genes involved in transport and metabolism 
of other carbohydrates such as glycerol, galactose, rhamnose, and sorbitol were also induced by 
bile. A putative ABC transporter operon (LSL_0220-0222; Fig. S2A), was up-regulated in both 
wild-type and bsh1 mutant. This operon was also induced by cholate exposure (see below). Down 
regulated genes in both strains included those for a putative EPS biosynthesis cluster, prophage 
Sal2 (60), arginine and proline metabolism, amino acid transporters and a manganese transport 
protein. 
A much larger gene set (813 between wild-type and mutant combined) was differentially 
expressed upon exposure to cholate, and the range of expression fold-change values was 
considerably higher (Table 3). Prominent among these genes were those for classical stress 
response proteins (GroEL, GroES, chaperones, Clp proteases), as well as diverse transporters (Opp 
system, ABC transporters, MDR transporters). There was generally excellent concordance 
between wild-type and the bsh1 mutant, both in the identity and fold changes of the genes.  
The most significant changes were class I heat-shock genes (groELS, grpE); a gene (hrcA) 









the ATP-dependent ClpP protease (LSL_1168) were also up-regulated by cholate, as was 
expression of the clpP expression regulon ctsR.  
A diverse collection of genes encoding transporters, efflux pumps, Na+/H+ antiporter, oxidase 
proteins, reductase proteins, membrane proteins and diverse hydrolases were also up-regulated by 
cholate exposure, indicating that the products of bile deconjugation put osmotic, oxidative, and pH 




























Members of the species L. salivarius have a broad ecological distribution, reflected in the 
strains chosen for this study (Table 2). That all strains examined have a bsh1 gene resident on their 
respective circular megaplasmid testifies to the biological selection on this gene, and the stability 
of the megaplasmid as its physical location. Two strains were shown to have a second bsh2 gene, 
but only because draft genome sequence was available for one of these strains. When assessing the 
overall bile resistance phenotypes of the strains herein, it must be noted that other additional bsh 
genes may be present in a given strain. Thus, although the group D BSH1 enzyme present in strain 
NCIMB8816 is expected to be inactive, this strain showed deconjugation activity for TDCA. 
Phylogenetic analysis showed that the L. salivarius BSH1 and BSH2 protein are in two different 
branches of the BSH tree. This is unsurprising given that a distinguishing feature of the genus 
Lactobacillus is its extraordinary phenotypic and genomic diversity (9), and that lateral gene 
transfer is an important element in generating this diversity (41).  
The strain L. salivarius UCC118 was selected for human probiotic applications based initially 
upon a number of criteria, including bile resistance (18). Thus, although the BSH of this strain was 
shown herein to have relatively low activity according to a traditional plate test, the MIC values of 
the strain for GDCA, porcine bile and bovine bile were as high, or higher, than almost all strains 
tested. More consistent with the plate assay, the recombinant 118BSH1 protein was less active 
against all substrates tested than the corresponding BSH1 protein from strain JCM1046, in 
particular against tauro-congugated bile acids.  The biochemical characterization also revealed a 
striking difference in preference for glyco-conjugated substrates shown by the 118BSH1 enzyme, 


























may be due in part to the internal deletion of eight residues in the group A BSH1 enzyme, including 
Asn171, considered to be part of the conserved active site. However, there are 12 other single 
amino acid residue differences (of which seven are conservative substitutions) between 1046BSH1 
and 118BSH1, that may also be important.  A structural comparison between these two enzymes 
will give an interesting insight into how these changes impact on folding, substrate recognition and 
activity.  Notably however, disruption of the bsh1 gene (LSL_1801) led to a dramatic reduction in 
bile tolerance in vitro, and significant reduction in murine transit survival. It is significant therefore 
that the relatively low activity of the 118BSH1 protein does not detract from its likely biological 
importance. We were unable to purify soluble 47825BSH1 protein, corresponding to group B 
proteins that harbor the internal deletion spanning Asn171 as well as the carboxy-terminal 
truncation. Three of the five strains encoding group B BSH proteins are extra-intestinal in origin, 
where production of active BSH would be less critical. However, L. salivarius strains of 
extra-intestinal origin were not consistently more bile-sensitive than intestinal isolates. This 
probably reflects the unreliability of assigning definitive origins/sources to strains of a species that 
can survive in many niches. 
The enzymatic properties of the more active BSH1 protein of JCM1046 are presented for 
comparative purposes with other bacterial BSH enzymes in Table 4. The Km of L. salivarius 
1046BSH1 for TCA is higher than those from L. johnsonii and B. longum, suggesting that TCA is a 
better substrate for these enzymes.  However, the C-terminal His-tag present on the 1046BSH1 
enzyme may affect the affinity for the substrate. Unlike BSH from B. longum, 10461BSH1 from L. 
salivarius JCM1046 showed higher activity against tauro-conjugated bile acids than 
glyco-conjugated ones. This may be related to different locations of lactobacilli and bifidobacteria 


























 1046bsh2 is most similar to Lreu23DRAFT_0782 (JGI gene ID 639134569), which is not 
biologically characterized. The bsh2 gene is the only additional enzyme related to bile degradation 
that we annotated in the JCM1046 draft genome sequence. Plate assay showed that 
JCM1046Δbsh1 had lost activity against TDCA and its activity against GDCA was retained, albeit 
at reduced level compared to the wild type strain JCM1046. This suggested that bsh2 was 
responsible for enhanced GDCA resistance in strains JCM1046 and LMG14476. Detailed 
structural comparison of 118BSH1, 1046BSH1 and 1046BSH2 will provide valuable insights into 
related BSH molecules of a single species that have dramatically different activities and substrate 
profiles. 
Exposure of L. salivarius early log-phase cells to bile or cholate did not induce the expression 
of bsh1. Genes for BSH were also not induced by bile in L. acidophilus (47) contrasting with 
induction of bsh expression in L. plantarum WCFS1 by bile (7) and in B. longum NCC2705 by 
simulated intestinal stress conditions (63). It remains possible that L. salivarius bsh1 expression is 
inducible in vivo, modulated by factors other than bile. Bile exposure caused differential 
expression of a large set of genes whose products are implicated in the BSH-independent bile MIC 
values of the strains tested. The altered cell activities are primarily in the categories of 
carbohydrate metabolism, cell surface remodeling, stress response, and transport/efflux, many of 
which are readily rationalized as contributing to resistance to a detergent-like molecule. Broadly 
similar categorizations of bile response were demonstrated for L. acidophilus (47) and L. reuteri 
(62), with important genes distinctive to each species. For example, differential expression of a 
7-kb eight-gene operon encoding a two-component regulatory system was central to L. acidophilus 
bile response (47), whereas none of the L. salivarius two-component regulator systems were 


























salivarius, although one gene product, LBA1425, shows 44% amino acid identity to LSL_1464, 
which was significantly up-regulated by bile.  LSL_1464 is a putative alpha-beta hydrolase of 
unknown function that is conserved in other lactobacilli, Listeria, and some other Firmicutes, and 
that merits functional characterization. A presumptive ABC transporter locus (Fig. S2A) that might 
act as an efflux pump for bile was significantly up-regulated in L. salivarius, and this ABC 
transporter locus is conserved in many bacteria (not shown). A second ABC transporter locus 
induced by cholate (LSL_0031-0033) was 29% identical at protein level to Lr1265, which was 
induced by bile stress in L. reuteri (62). Although altered carbon metabolism might be required to 
maintain cellular ATP levels to energize bile export processes, it is more likely that induction of e.g 
the mannose and sorbitol PTS systems is due to denaturation of their presumptive regulators.  
The LSL_1335 gene was up-regulated 2.6 fold in response to bile. This gene encodes a 
putative mucin-binding protein and candidate adhesion LspC, and was previously shown by us not 
to be expressed in vitro (59). Bile may thus be used as a signaling molecule by commensal 
lactobacilli like L. salivarius to modulate host-interaction genes. Consistent with this notion, genes 
for three surface proteins of L. acidophilus, including two putative mucin-binding proteins, were 
up-regulated upon bile exposure (47). 
The toxicity of free bile acids produced by BSH activity can be avoided either through 
catabolism or by export. According to the annotated genome, L. salivarius UCC118 has neither 
7α-dehydroxylate nor 7α-dehydrogenate activity for unconjugated bile acid, nor does it contain 
genes encoding cholate-CoA ligase (EC 6.2.1.7) which can further break down free bile acids 
(cholate, deoxycholate and chenodeoxycholate). Thus the cholate-induced efflux pumps and 
transporters likely play a role in removal of unconjugated bile acids in L. salivarius strains. Among 


























B) showed highly identity (71% and 59%) to the characterized MDR transporters from L. 
acidophilus NCFM (LBA1429) (47) and L. reuteri ATCC55730 (lr1584) (62) which contribute to 
bile resistance. Another cholate induced L. salivarius MDR transporter (Fig. S2B, LSL_0032-3) 
are 52% and 53% identical to the L. lactis LmrCD cholate transporter, which also confer bile 
resistance on these bacteria (64).The Opp system (LSL_2026-7) located on the 44-kb plasmid 
pSF118-44 which is responsible for glycine-betaine uptake was also induced by cholate. These 
gene products show high homology to the L. monocytogenes BilE system (57% and 45% identity 
to BilB and BilA ) which has been shown to enhance bile resistance when introduced into 
Bifidobacterium and Lactococcus (61). Thus the products of BSH activity can induce the 
expression of genes and gene products that potentiate the bile resistance phenotype of the organism, 
potentially amplifying the phenotypic significance of the BSH kinetics of a particular enzyme 
complement in a given strain. 
BSH enzymes are clearly key contributors to bile resistance levels, and might conceivably be 
the most important determinant under growth phase and nutritional conditions that cannot be 
reproduced easily outside the gut. However, the Lactobacillus cell is equipped with a repertoire of 
other mechanisms involved in protecting the cell against the inimical properties of bile, and which 
result in a bile resistance level that cannot be predicted simply from consideration of the BSH 
enzyme complement alone. Independent of its function in dietary fat emulsification, bile is a key 
signaling molecule regulating its own biosynthesis, lipid absorption, cholesterol homeostasis, and 
local mucosal defenses in the intestine (29). Weight gain in chickens in inversely correlated with 
intestinal BSH activity, much of which comes from the dominant lactobacillus species in poultry, L. 
salivarius (27). Excessive deconjugation of bile in the gut may be linked with “contaminated small 







a human probiotic, has low BSH activity, but high overall bile resistance. This study shows the 
complexity of bile-resistance level determination in commensal L. salivarius strains, the 
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Fig. 1. Southern hybridization analysis of presence of bsh1 (LSL_1801) homologues in L. 
salivarius strains. (A), separation of S1-nuclease treated genomic DNA of L. salivarius strains by 
pulse-field gel electrophoresis; (B), corresponding Southern hybridization using the L. salivarius 
UCC118 bsh1 (LSL_1801) probe 
 
Fig. 2. Sequence alignment of L. salivarius LSL_1801 homologues encoding BSH1 enzymes. 
Sequences were aligned with ClustalW (http://www.ebi.ac.uk/Tools/clustalw/). Identical amino 
acids are marked by an asterisk, conserved and semi-conserved substitutions are marked by two 
dots and a single dot, respectively. Shaded residues are conserved amino acids implicated in active 
site. L. salivarius BSH1 gene amplicons were sequenced with primers FF029 and FF30 and were 

















Fig. 3. Detection of L. salivarius BSH activity by plate assay. 
-, no BSH activity; +, w, positive bile salt hydrolase activity, production of opaque white colonies; 
+, p, positive, formation of precipitation; -/+, w, weak BSH activity, formation of opaque white 
colonies 
 
Fig. 4. Relative expression of bsh1 genes in 3 representative L. salivarius strains. Expression 
values graphed are ratios of bsh1: groEL gene expression in respective strains, normalized against 




























Fig. 5. Disruption of bsh1 (LSL_1801) in L. salivarius LS201 
(A) Southern hybridization analysis of insertional inactivation of the bsh1 gene in L. salivarius 
LS201. LS201 and LS201Δbsh1 genomic DNA were digested with SpeI (Lane 1-2) and hybridized 
with a labeled 582-bp amplicon of LSL_1801 (primers FF027 and FF028) as a probe. M, labeled 
DNA marker; 1, L. salivarius LS201 (derivative of L. salivarius UCC118 cured of pSF118-20; 2, L. 
salivarius LS201Δbsh1. DNA sizes are indicated by arrows. 
(B) Schematic representation of the relevant regions of the LS201 and LS201Δbsh1 genomes. 
Heavy lines represent megaplasmid DNA; thin lines represent plasmid DNA. bsh1 (LSL_1801) is 
presented by the arrow, and the grey box is the bsh1 internal fragment corresponding to the 
hybridization probe. SpeI sites are indicated 
 
Fig. 6. BSH1 and BSH2 contribute to bile resistance in L. salivarius. 
(A) Survival of L. salivarius LS201 in the presence (open symbols) or absence (closed symbols) of 
0.2 % porcine bile. Big squares, L. salivarius LS201; triangles, L. salivarius LS201Δbsh1; cycles, 
L. salivarius LS201ΔlacZ; diamonds, L. salivarius LS201Δbsh1(pLS219 [pLS209+118bsh1]); 
small squares, L. salivarius LS201Δbsh1(pLS209) 
(B) Survival of L. salivarius JCM1046 in the presence (open symbols) or absence (closed symbols) 
of 0.1 % porcine bile. Squares, wild type L. salivarius JCM1046; triangles, L. salivarius 
JCM1046Δbsh1 
(C) Disruption of the bsh1gene of LS201 reduces survival during murine intestinal tract transit. 
Grey bars, L. salivarius LS201Δbsh1; white bars, L. salivarius LS201ΔlacZ. 
 
Fig. 7. Purification of recombinant L. salivarius BSH1 proteins. 
















Rosetta DE3 cell lysate showing expression of His-tagged BSH1;  H, IMAC-purified BSH1; G, 
gel filtration-purified BSH1. Protein marker sizes are indicated. 
 
Fig. 8. (A) pH and substrate dependence of L. salivarius BSH1 enzymes. 
White bars, tauro-CBAs; Grey bars, glyco-CBAs; T/GDCA, tauro/glycodeoxycholate; T/GCA, 
tauro/glycocholate; T/GCDCA, tauro/glycochenodeoxycholate 
(B) Measurement of 1046BSH1 Km and Vmax for TCA  
 
Fig. 9. Genome atlas of global bile-responsive and cholate-responsive transcriptomes in L. 
salivarius strains. 
Genome wheels with microarray results were generated by Microbial Genome Viewer 
(http://www.cmbi.ru.nl/genome/). The scale represents the log2 transformation of the changes in 
gene expression (treated/untreated) projected on a linear color gradient. 
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871 Table 1. Bacterial strains and plasmids 
Strain or plasmid Relevant propertiesa Source or reference 
Strains   
L. salivarius   
UCC118 Ileocaecal isolate from a human adult (11) 
LS201 pSF118-20 free derivative of strain UCC118 (21) 
LS201Δbsh1 LS201 integrant LSL_1801 (bsh1)::pLS216 This work 
LS201ΔlacZ LS201 integrant LSL_0376 (lacZ)::pLS217 This work 
JCM1046Δbsh1 JCM1046 integrant bsh1::pLS218 This work 
   
E. coli   
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araΔ139 Δ(ara-leu)7697 
galU galK rpsL(StrR) endA1 nupG 
Invitrogen 
Rosetta BL21(DE3)pLysS F- ompT hsdSB (rB B-mB-) gal dcm (DE3) pLysS (CmR) Invitrogen 
   
Lactococcus lactis   
LL108 Strain with repA gene integrated in chromosome (35) 
   
Plasmids   
pORI19 Emr Ori+ RepA- lacZ’ derivative of pROI28 (33) 
pPTPL Tetr, promoter probe vector (8) 
pVE6007 Cmr, temperature sensitive, derivative of pWV01, lactococcal cloning vector (40) 
pLS209 Emr, Lactobacillus gene cloning vector, a derivative of pLS203 produced by PCR (21) 
pLS215 Tetr, derivative of pORI19, erm is replaced with tet from pPTPL Unpublished resultsb
pLS216 Tetr, derivative of pLS215 containing a 558–bp internal gene fragment of bsh1 (UCC118) This work 
pLS217 Tetr, derivative of pLS215 containing a 1002–bp internal gene fragment of lacZ (LSL_0376) This work 
pLS218 Emr, derivative of pORI19 containing a 582–bp internal gene fragment of bsh1(JCM1046) This work 
pLS219 Emr, derivative of pLS209 containing bsh1 (LSL_1801) gene and its promoter region This work 
pOPINE Ampr, derivative of pTriEx2 with a C-6 ¯ His-tag fusion OPPFc
pEB118 Ampr, derivative of pOPINE for expression of C-His-tagged 118bsh1 This work 
pEB1046 Ampr, derivative of pOPINE for expression of C-His-tagged 1046bsh1 This work 






b, contributed by Jan-Peter van Pijkeren 
c, In-fusion cloning vector contributed by Oxford Protein Production Facility (OPPF) 
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876 Table 2. BSH activity and bile resistance of L. salivarius strains  
BSH1 group  Strain Origin Plate assay activity MIC 
  






A UCC118 Human ileal-caecal region -/+ (w) - 6 >20 >5.0 
A NCIMB 8818 St. Ivel cheese -/+ (w) - 5 10 1.0 
A CCUG 27530B Human abdomen -/+ (w) - 5 7.5 0.3 
A JCM 1047 Swine intestine - - 4 6.0 0.2 
B CCUG 47825 Human blood - - 4 >20 >5.0 
B CCUG 45735 Human blood - - 6 >20 >5.0 
B CCUG 38008 Human gall - - 6 15 >5.0 
B CCUG 47826  Human blood - - 6 15 >5.0 
B L21 Human feces - - 4 15 1.0 
B AH 4231 Human ileum-caecal - - 6 12 0.5 
C JCM 1046 Swine intestine + (p) + (p) >15 >20 >5.0 
C LMG 14476 Cat with myocarditis + (p) + (p) >15 >20 >5.0 
C DSM 20492 Human saliva + (w) - 10 >20 >5.0 
C 01M14315 Human gallbladder pus + (w) - 6 >20 >5.0 
C JCM 1040 Human intestine + (w) - 6 15 >5.0 
C CCUG 44481 Bird + (p) - 4 >20 >5.0 
C DSM 20555 Human saliva + (w) - 4 12 >5.0 
C JCM 1045 Human intestine + (p) - 5 >20 1.5 
C CCUG 47171 Human tooth plaque + (p) - 5 12 1.0 
C CCUG 43299 Human blood + (w) - 6 >20 0.4 
C NCIMB702343 unknown + (p) - 5 >20 0.4 
C DSM 20554 Human saliva + (p) - 5 10 0.4 
C NCIMB 8817 Turkey feces + (p) - 6 10 0.8 
C UCC119 Chicken intestine + (w) - 4 15 0.2 
D NCIMB 8816  Human saliva + (p) - 6 12 >5.0 
D JCM 1042 Human intestine - - 4 10 1.0 
 JCM 1230 Chicken intestine - - 6 >20 >5.0 
 LS201 UCC118 derivative - - >15 >20 >5.0 
 LS201Δbsh1 This study - - 3 4.0 0.1 
 JCM1046Δbsh1 This study - + (p) 6 >20 >5.0 
TDCA, sodium taurodeoxycholate hydrate; GDCA, sodium glycodeoxycholate; MIC, minimm 
inhibitory concentration; -, no BSH activity; + (w), positive bile salt hydrolase activity, production 
of opaque white colonies; + (p), positive, formation of precipitation; -/+ (w), weak BSH activity, 






Table 3. Comparison of number of genes ordered in COG categories significantly affected by bile extract porcine with that by
cholate  
Bile/Cholate induced gene regulation Up-regulated Down-regulated
LS201 LS201Δbsh LS201 LS201ΔbshFunctional categories bile cholate bile cholate bile cholate bile cholate
 Information storage and processing 3 17 2 26 6 37 5 65
J Translation, ribosomal structure and biogenesis 1 0 1 2 0 21 0 42 
A RNA processing and modification 0 0 0 0 0 0 0 0 
K Transcription 2 8 1 11 1 6 3 12 
L Replication, recombination and repair 0 9 0 13 5 10 2 11 
B Chromatin structure and dynamics 0 0 0 0 0 0 0 0 
 Cellular processes and signaling 8 49 7 68 8 25 9 43 
D Cell cycle control, cell division, chromosome partitioning 0 0 0 2 1 4 1 4 
V Defense mechanisms 2 13 2 18 2 5 1 13 
T Signal transduction mechanisms 0 2 0 4 2 4 2 5 
M Cell wall/membrane/envelope biogenesis 4 7 4 9 2 9 5 15 
N Cell motility 0 0 0 1 0 1 0 1 
Z Cytoskeleton 0 0 0 0 0 0 0 0 
W Extracellular structures 0 0 0 0 0 0 0 0 
U Intracellular trafficking, secretion, and vesicular transport 0 1 0 1 1 2 0 2 
O Posttranslational modification, protein turnover, 2 26 1 33 0 0 0 3 
 Metabolism 37 134 17 165 28 93 24 150 
C Energy production and conversion 5 13 3 20 1 3 1 7 
G Carbohydrate transport and metabolism 23 18 8 22 3 25 6 37 
E Amino acid transport and metabolism 3 58 3 64 19 32 13 59 
F Nucleotide transport and metabolism 0 1 0 2 2 3 1 6 
H Coenzyme transport and metabolism 0 12 0 12 0 0 0 2 
I Lipid transport and metabolism 1 5 1 10 0 12 0 14 
P Inorganic ion transport and metabolism 5 23 2 29 3 12 3 18 
Q Secondary metabolites biosynthesis, transport and 0 4 0 6 0 6 0 7 
 Poorly characterized 20 40 4 55 5 21 2 32 
R General function prediction only 6 32 4 44 2 14 1 22 
S Function unknown 3 8 0 11 3 7 1 10 
 Unknown COG functions 11 0 0 2 0 0 0 0 
 Total number of gene expressed differentially 64 189 34 248 59 151 34 225 
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Table 4. Comparison of BSH enzymatic properties. 






(mM GCA) Reference 
LS1046BSH1 36.5 3.5-7.5 tauro-CBA 1.976 ND This study 
LJBSHA/B 42 3.8-4.5 equal 0.76/0.95 NT (39) 
LABSH 34 5-7 tauro-CBA NT NT (46) 
BLBSH 35 5-7 glyco-CBA 1.12 0.16 (56) 
BLBSH - 6.5 equal 0.032 0.022 (30) 
BFBSH 32.5 4.2 equal 0.45 0.35 (54) 
BRBSH 28 3-11 glyco-CBA NT 3.08 μM (GDCA) (53) 
CPBSH 56 5.8-6.4 glyco-CBA NT 0.5 (22) 
XMCGH 52 7.9-8.5 equal NT 1.1 (15) 
LS, L. salivarius; LJ, L. johnsonii; LA, L. L. acidophilus; BL, Bifidobacterium longum; BF, Bacteroides fragilis; BR, 
Brevibacillus sp; CP, Clostridium perfringens; XM, Xanthomonas maltophilia; CGH, cholylglycine hydrolase; equal, BSH does

























Fig. S1. Phylogenetic analysis of BSH from Lactobacillus and other bacteria 
Neighbor-joining tree of BSH from different bacteria. Sequences were aligned and 
analyzed by MEGA4 using the p-distances amino acid model with 500 bootstrap 
replications. P12256 (penicillin V acylase) from Bacillus sphaericus was used as an 
outgroup. Accession numbers are to right of strain name abbreviations. BL, 
Bifidobacterium longum; BS, Bacillus sphaericus; CP, Clostridium perfringens; EF, 
Enterococcus faecium; LA, L. acidophilus; LG, L. gasseri; LJ, L. johnsonii; LM, Li. 
monocytogenes; LP, L. plantarum; LR, L. reuteri; LS, L. salivarius; MS, 
Methanobrevibacter smithii 
 
Fig. S2. Bile and cholate induced ABC transporter operons in L. salivarius 
 
Table S1. Primers used in this study 
 
Table S2. Genes significantly up/down-regulated by porcine bile extract (expression ratio 
≥ 2-fold, p < 0.05) 
 
Table S3. Genes significantly induced by cholate (expression ratio ≥ 2-fold, p < 0.05, 
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LDL FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINEDGLGMAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEQV I ITPAEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YF DAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJ ILGQC 
LDL • FSYGEQV I ITPAEYEFKFRKEKA IKNHKSL I GVGI V ANDYPL YF DAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJ ILGQC 
LDL FSYGEQV I ITP AEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQVI ITP AEYEFKFRKEKAIKNHKSL I GVG I V ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEEVI ITPAEYEFKFRKEKAIKNHKSL I GVGI V ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQV I ITPAEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINEDGLGMAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYSEEVI ITPAEYEFKFRKEKAIKNHKSL IGVGI V AND YPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJ ILGQC 
LDL'FSYGEEVIITPAEYEFKFRKEKAIKNHKSLIGVGI VANDYPLYFD AINEDGLGMAG FPGNAYYSDALENDKDNITPFEFIPIJILGQC 
LDL FSYGEEVI ITPAEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEQVI ITP AEYEFKFRKEKAIKNHKSL I GVG IVADDYPL YFDAINEDGLGMAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEQVI ITP AEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQVI ITP AEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL • FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVGI V ANDYPL YF DAINEDGLGIIAG FPGNAYYSDALEND KDNITPFEF IP IJ ILGQC 
LDL • FSYGEQV I ITPAEYEFKFRKEKAIKNHKSL I GVGI V ANDYPL YF DAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YF DAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYGEQVI ITP AEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINEDGLGMAG FPGNAYYSDALENDKDNITPFEF IP IJILGQC 
LDL FSYSEEVI ITPAEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YFDAINKDGLGIUG FPGNAYYSDALENDKDNITPFEF IPIJILGQC 
LDL FSYGEQV I ITPAEYEFKFRKEKAIKNHKSL I GVG IV ANDYPL YFDAINEDGLGIIAG FPGNAYYSDALEND KDNITPFEF IPIJILGQC 
LDL • FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL IGVGI V ANAYPL YFDAINEDGLGIIAG FPGNAYYSDALENDKDNITPFEF IP IJ ILRQC 
LDL FSYGEQVI ITPAEYEFKFRKEKAIKNHKSL I GVGIV ANDYPL YF DAINEDGLGMAG FPGNAYYSNALEND KDNITPFEF IPIJILGQC 
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SDVNEARNLVEKINLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVHIYD------- PEFNYQIIYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVHI YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGI GLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIAGREKS IVVEVTKSGVHVYDNPVGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIAGREKS IVVEVTKSGVHVYDNPVGVL PEFNYQIIYNLNKYRNLSISTPQNTFSDSVD LKVDGTGFGGI GLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLI AGREKS IVVEVTKSGVHVYDNPVGVL PEFNYQIIYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEVRNLVERINLINLSFSEQLPLAGLHIJLIADREKSIVVEVTKSGVHVYDNPVGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YDNPIGVLn PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVHIYDNPIGVLn PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVER INLINLSFSEQLPLAGL HIJLI ADREKS IVVEVTKSGVH I YDNPIGVL PEFNYQMYNLNKYRNLSISTPQNTF SDSVDLKVDGTGFGGI GLPGDVS 
SDVNEARNLVER INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YDNPIGVL PEFNYQJ1YNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINL I NLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YDNPIGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDAS 
SDVNEARNLVEKINLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEKINLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEKINL INLSFSEQLPLAGLHIJL IADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQIIYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVEK INLINLSFSEQLPLAGLHIJLIADREKS IVVEVTKSGVH I YD------- PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLIADREKSIVVEVTKSGVHIYDNPIGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLI ADREKS IVVEVTKSGVR I YDNPIGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLI ADREKS IVVEVTKSGVH I YDNPIGVLn PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLI ADREKS IVVEVTKSGVH IYDNPIGVL PEFNYQMYNLNKYRNLSISTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
SDVNEARNLVERINLINLSFSEQLPLAGLHIJLI ADREKS IVVEVTKSGVH I YDNPIGVL PEFNYQMYNLNKYRNLSINTPQNTFSDSVDLKVDGTGFGGIGLPGDVS 
1:1;1;1;1; 1t1;1t1t1;o1;1;1;1;1;1t1tt;1t1t1n':1t1t1l:1;1t":'l'1;1;1;1; 1:1:1:1;1;1;1;1;1;1;1;1;1;1: •• 1:1; 1;1;1;l\"1;1;1;1t1t1;'lt1:1;t;1;1;1t1;1t 1;1;1;1;1;1;1;1;1;1;1t1nt1nt1:1t1t1;1;1;1t1t1;1;1;1; 1: 
. . ... . . 
230 240 250 260 270 280 290 300 3 10 320 
-- 1----1---- 1- -- 1----1- - 1- -1---- 1- --1---- 1---- 1- --1---- 1----1---- 1---- 1----1- -- 1- --1---- 1--
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVGQI KGVNKTESGKEEYTVYSNCYDLDNKTLYYTTYENRQIVAVTLNK DKDGNRLVTYPFERKQIINKLN 
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVGQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNKD KDGNRLVTYPFERKQIINKLN 
PES FVRAAFSKLNSS KGTTVEED I TQF F HI LGTVGQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIV AVTLNKD KDGNRLVTYPFERKQI INKLN 
PES FVRAAFSKLNSS KGTTVEED I TQF F HI LGTVGQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQ IV AVTLNKDKDGNRLVTYPFERKQI INKLN 
PES FVRVAFSKLNSSKGTTVEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYD LDNKTL YYTTYENRQIVAVTLNKDKDGNRLVTYPFERKQIINKLN 
PES FVRVAFSKLNSSKGTTVEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNKDKDGNRLVTYPFERKQIINKLN 
PES FVRIAFSKLNSSKGTTVEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNKDKDGNRLVTYPFERKQIINKLN 
PES FVRATFSKLNSSKETTVEED ITQF FHILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNKD KDGNRLVTYPFERKQIINKLN 
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNE DKDGNRLVTYPFERKQIIKKLN 
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVSVTLNKDKNGNKLVVYPFERKQIINKLN 
PES FVRAAFSKLNSSKGTTVEEDITQFFHILGTIEQI KGVNKTESGKEEYTVYSNCYD LDNKTL YYTTYENRQIVSVTLNKDKNGNKLVVYPFERKQIINKLN 
PES FVRAAFSKLNSSKGTTVEEDITQFFHILGTVEQIKGVNKTESGKEEYTVYSNCYDLDNKTLYYTTYENRQIVSVTLNKDKNGNKLVVYPFKRKQIINKLN 
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVSVTLNKDKNGNKLVVYPFERKQIINKLN 
PES FVRAAFSKLNSSKGTTLEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE---------------------------------
PES FVRAAFSKLNSSKGTTLEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE---------------------------------
PES FVRAAFSKLNSSKGTTLEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE- ------------------------ --------
PES FVRAAFSKLNSSKGTTLEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE---------------------------------
PES FVRAAFSKLNSSKGTTLEEDITQF FHILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE---------------------- - ----------
PES FVRAAFSKLNSSKGTTLEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYE---------------------------------
PES FVRAAFSKLNSSKGTTVEED ITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNE DKNGNRLI AYPFERKQV INKLN 
PES FVRAAFSKLNSSKGTTVEEDITQFFHILGTVEQIKGVNKTESGKEEYTVYSNCYDLDNKTLYYTTYENRQIVAVTLNEDKNGDRLIAYPFERK-------
PES FVRAAFSKLNSS KGTTVEED I TQF F HI LGTVEQ I KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQ IV AVTLNE DKNGNRL I A YSFERKQV INKLN 
PES FVRAAFSKLNSSKGTTVEEDITQFFHILGTVEQIKGVNKTESGKEEYTVYSNCYDLDNKTLYYTTYENRQIVAVTLNEDKNGNGLIAYPFERKQVINKLN 
PES FVRAAFSKLNSSKGTTVEEDITQFF HILGTVEQI KGVNKTESGKEEYTVYSNCYDLDNKTL YYTTYENRQIVAVTLNE DKNGNRLI AY PFERKQV INKLN 
1;1;.1;1;1;1';'11"1\"'1\"'1\"1;1;1';1;1;. 
. . 
Strain BSHl MRS TDCA GDCA BSH activity 
Group TDCA GDCA 
UCCl18 A -1+, w 
CCUG47825 B 
JCM1046 C +,p +,p 
NCIMB8816 D +,W 
stationary phase log phase 
1.5 
* * rf r-
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n l.E+02 ....L.. ....L.. or or 
2 4 6 24 48 72 
Time (h) 
58 kDa ~ 
46 kDa ~ 
30 kDa ~ 
118BSHl 1046BSHl 
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Inner ring I: LS201~bshl 
ring 2: LS201 
Log,(target/conlrol) 
-4 -2 0 2 4 
cholate transcriptome 
